Larvol Delta - Analyses-from-Cognitions-Positive-Phase-2-SHINE-Study-of-CT1812-in-MildtoModerate-Alzheimers-Disease-will-be-Presented-in-a-Podium-Presentation-at-CTAD

Elayta (CT1812) - Cognition Therap

https://www.globenewswire.com/news-release/2024/10/23/2967684/0/en/Analyses-from-Cognition-s-Positive-Phase-2-SHINE-Study-of-CT1812-in-Mild-to-Moderate-Alzheimer-s-Disease-will-be-Presented-in-a-Podium-Presentation-at-CTAD.html

Oct 23, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next